PRESS RELEASE published on 12/17/2024 at 18:45, 1 year 3 months ago HYMPULSION ORDERS 4 NEW HRS STATIONS AS PART OF THE HYDROGEN MOBILITY PROGRAM "ZERO EMISSION VALLEY" IN THE AUVERGNE-RHONE-ALPES REGION (FRANCE) HRS receives new order from HYmpulsion for hydrogen refueling stations in Auvergne-Rhône-Alpes, part of ZEV project. Total of 8 stations ordered. Thierry Raevel and Hassen Rachedi comment on collaboration Hydrogen HRS Refueling Stations HYmpulsion ZEV Project
REGULATED PRESS RELEASE published on 12/17/2024 at 18:31, 1 year 3 months ago Damartex réaffirme son éligibilité au PEA-PME Damartex réaffirme son éligibilité au PEA-PME, ouvrant ainsi la possibilité d'intégrer ses actions dans les comptes PEA-PME. Le groupe vise à devenir un leader européen de la Silver Economy Damartex PEA-PME Actions Éligibilité Silver Economy
PRESS RELEASE published on 12/17/2024 at 18:16, 1 year 3 months ago Public tender offer for all publicly held registered shares of Orascom Development Holding AG by its main shareholder LPSO Holding Ltd. Orascom Development Holding AG announces public tender offer for all publicly held shares by main shareholder LPSO Holding Ltd. at a premium price. Board refrains from recommendation Tender Offer Orascom Development Holding AG Premium Price Publicly Held Shares LPSO Holding Ltd
PRESS RELEASE published on 12/17/2024 at 18:15, 1 year 3 months ago THERANEXUS FAIT UN POINT SUR SA POSITION DE TRÉSORERIE ET SON HORIZON DE FINANCEMENT Theranexus annonce sa trésorerie au 12 décembre 2024 à 1,5 M€, prévoit un renforcement de 4,8 M€ et étend son horizon financier jusqu'au T1 2026. Accord avec Exeltis et réaménagement de sa dette soulignés Dette Trésorerie Theranexus Exeltis Horizon Financier
PRESS RELEASE published on 12/17/2024 at 18:15, 1 year 3 months ago THERANEXUS PRESENTS AN UPDATE OF ITS CASH POSITION AND FINANCING HORIZON Theranexus presents an update of its cash position and cash flow horizon, expecting improvement through upcoming payments and restructuring agreement with banking partners Cash Position Cash Flow Financial Debt Theranexus Banking Partners
PRESS RELEASE published on 12/17/2024 at 18:09, 1 year 3 months ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC purchased 50,000 of its own shares as part of a buyback program. The company now holds 3,877,562 shares in treasury London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Treasury Shares Numis Securities Limited
PRESS RELEASE published on 12/17/2024 at 18:01, 1 year 3 months ago CPI PROPERTY GROUP – Results of the Share Buy-back Offer CPI Property Group announces results of share buy-back offer with shareholders tendering over 182 million shares for about €145 million. Reduction in distribution ratio for 2024 Share Buy-back Shareholders CPI Property Group Distribution Ratio Prudent
PRESS RELEASE published on 12/17/2024 at 18:00, 1 year 3 months ago DRONE VOLT annonce un plan d'économies et confirme son objectif d'EBITDA positif dès 2025 DRONE VOLT annonce la rationalisation de ses coûts avec la fermeture de filiales et une réduction des coûts fixes pour atteindre un EBITDA positif en 2025 EBITDA Positif DRONE VOLT Filiales Rationalisation Coûts Fixes
PRESS RELEASE published on 12/17/2024 at 18:00, 1 year 3 months ago THERANEXUS ET EXELTIS (INSUD PHARMA) ANNONCENT UN ACCORD DE LICENCE POUR LA COMMERCIALISATION DU TX01 DE THERANEXUS DANS LE TRAITEMENT DE DEUX MALADIES NEUROLOGIQUES RARES Exeltis obtient une licence exclusive pour commercialiser la nouvelle formulation TX01 de Theranexus dans le traitement de deux maladies neurologiques rares en Europe. Des paiements d'étapes et de redevances prévus Maladies Rares Accord De Licence Theranexus Neurologie Exeltis
PRESS RELEASE published on 12/17/2024 at 18:00, 1 year 3 months ago THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE LICENSING AGREEMENT TO COMMERCIALIZE THERANEXUS TX01 FOR TWO RARE NEUROLOGICAL DISORDERS Theranexus and Exeltis sign license agreement for TX01, expanding treatment for rare neurological diseases. Exeltis to market TX01 across Europe and other regions License Agreement Theranexus Neurological Diseases Exeltis TX01
Published on 04/11/2026 at 02:00, 1 day 19 hours ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 04/11/2026 at 01:40, 1 day 20 hours ago Arctic Fox Announces Closing of Final Tranche Of Non-Brokered Private Placement
Published on 04/11/2026 at 00:30, 1 day 21 hours ago Trans Canada Gold Corp. Announces Proposed Warrant Extension
Published on 04/12/2026 at 21:25, 21 minutes ago CGTN AMERICA & CCTV UN: UN Chinese Language Day Celebration with "Chinese Language Shining Civilizations" Event
Published on 04/12/2026 at 20:15, 1 hour 31 minutes ago CGTN AMERICA & CCTV UN: Commemoration of 55th Anniversary of Ping-Pong Diplomacy Held in Beijing
Published on 04/11/2026 at 16:45, 1 day 5 hours ago CGTN: One family: Xi Jinping stresses keeping future of cross-Strait ties in Chinese hands
Published on 04/11/2026 at 16:40, 1 day 5 hours ago VARON Delivers Advanced Portable Oxygen Concentrator to Meet Rising Demand in Europe
Published on 04/11/2026 at 16:30, 1 day 5 hours ago VARON Oxygen Concentrators Meet Rising Demand for Modern Oxygen Therapy in Germany
Published on 04/11/2026 at 16:29, 1 day 5 hours ago Décès de Madame Jacqueline Himsworth, Présidente du Conseil d’administration de Manitou Group
Published on 04/11/2026 at 16:29, 1 day 5 hours ago Passing of Madame Jacqueline Himsworth, Chairman of the Board of Directors of Manitou Group
Published on 04/10/2026 at 18:35, 2 days 3 hours ago Déclaration des transactions sur actions propres
Published on 04/10/2026 at 18:26, 2 days 3 hours ago EURAZEO ANNOUNCES THE SUCCESS OF ITS INAUGURAL 500 MILLION EURO BOND ISSUE